Agios Pharmaceuticals, Inc.
$AGIO
Public valuation for Agios Pharmaceuticals, Inc. (AGIO). Fair value, signal, and key metrics — no sign-in required.
Current Price
$30.55
43% Overvalued
Fair Value Estimate
$17
🚧
Turnaround
Negative earnings but showing signs of recovery
Analyst Consensus
Target: $45.88
50% higher than current
Key Metrics
Market Cap
$1.8B
Forward P/E
2.5x
Operating Margin
-247.1%
Revenue Growth
167.8%
Get free watchlist alerts
Join the waitlist for valuation updates on $AGIO and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.